This article is part of the supplement: B cells in autoimmune diseases: Part 1

Email this article to a friend

Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity

Henrik E Mei*, Stefanie Schmidt and Thomas Dörner

Arthritis Research & Therapy 2012, 14(Suppl 5):S1 doi:10.1186/ar3909

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?